BREAKING NEWS! Gilead Sciences, Inc. Wiggling Out of Remdesivir Liability by Throwing British and Portuguese Manufacturer Hikma Under the Bus And The US Chamber of Commerce Files an Amicus Brief

One patient suffered from glass shards in the vial, causing two strokes and a leg amputation and another one died - now put into a David and Goliath situation against two giants!

In rather stunning moves, Gilead claims other parties have liability, and the US Chamber of Commerce betrays the patients and the American public.

We reported that for the first time, a judge ruled that Big Pharma Gilead Sciences, Inc. must answer to patient harm suffered because of its product, Remdesivir.

We announced this important case on October 2nd:

The groundbreaking court decision allowing this lawsuit against Gilead was made by a Michigan judge. He is the first to decide that a drug manufacturer is NOT protected by the Public Readiness and Emergency Preparedness (PREP) Act in this case.

After receiving the intravenous COVID medication Remdesivir, also known as Veklury, that was contaminated with glass particles, patient Edward Pimentel suffered two strokes and a leg amputation. Another patient, represented by Deborah Fust, died.

This case was filed by Ven Johnson Law. 

A Significant Case Update